Cofounder CEO

Ally Tam Tumasova

Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

2025 Event

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2020 Event

2021 Event

LLC Menu Official

LLC Menu

Partner

Alyssa Jaffee

Tam is a consumer health and wellness investor-turned-operator, and cofounder CEO of Halle Berry's Respin Health, a digital health platform for menopause care and support. Tam was recognized by Forbes 30 Under 30 twice, first in 2019 and again in 2021 for her achievements as a venture capital investor. In her capacity as a venture investor, Tam deployed over $100 million in venture funding across primarily early stage consumer health/wellness and community-led companies, including Maven Clinic, Bobbie Baby, Co-Star, and Food52. Prior to founding Respin Health, Tam served as a Director of New Ventures at Redesign Health, a global venture studio dedicated to launching and scaling transformative healthcare companies. Her expertise sits at the intersection of consumer brand building, digital health, and technology.

Alyssa Jaffee is a Partner at 7wireVentures, a leading digital health-focused venture capital firm. She has backed and advised high-growth companies such as NOCD, Summer Health, Zerigo Health, and Brightline, serving in board roles and shaping strategy across the portfolio. Recognized by Business Insider’s 30 Under 40 and Crain’s 40 Under 40, Alyssa brings deep expertise in healthcare innovation, go-to-market strategy, and venture investing. Prior to joining 7wire, she was an investor at Pritzker Group Venture Capital and co-founded TransparentCareer, a platform for data-driven career decisions.

Beyond investing, Alyssa is actively involved in the healthcare and business communities, serving on venture boards and initiatives that support equity, access, and innovation. She holds degrees from the University of Wisconsin-Madison and Chicago Booth, and lives in Chicago with her husband and three sons. A fluent Spanish speaker and avid traveler, she’s also known for her love of food, community, and gatherings.

Dr. Alicia Zhou, PhD, serves as the Chief Executive Officer of the Cancer Research Institute (CRI), a premier global nonprofit driving transformative advances in cancer immunotherapy. Under her leadership, CRI is at the forefront of harnessing the immune system to fight and ultimately cure all cancers. Since 1953, CRI has invested over $500 million into groundbreaking research programs that bridge laboratory innovations with clinical applications, profoundly transforming cancer treatment and improving patient outcomes.
Before joining CRI, Dr. Zhou was the Chief Science Officer at Color Health, where she led initiatives to improve patients’ access to cancer prevention and screening towards better patient outcomes and population health. Additionally, she played a key role as a Steering Committee member and Principal Investigator for the National Institutes of Health (NIH)’s All of Us Research Program. This landmark initiative aims to ensure equitable and accessible precision medicine for all Americans. Dr. Zhou’s exceptional leadership and contributions were recognized in 2021 when she was named one of San Francisco Business Times’ 40 Under 40 and featured on Fierce Healthcare’s Most Influential Minority Executives List.
Dr. Zhou holds a B.S. in Biology from the Massachusetts Institute of Technology, a Ph.D. in Biological and Biomedical Sciences from Harvard University and completed her postdoctoral research in cancer biology at the University of California, San Francisco.


Alicia Zhou